Advertisement #1
Byondis
banners
Home Regulatory Updates Page 4

Regulatory Updates

Regulatory Updates

AbbVie booth at the 2019 annual meeting of the American Society of Clinical Oncology (ASCO) held June 1 - 4, 2019 in Chicago, Ill.

U.S. FDA Approves Venetoclax for the Treatment of Acute Myeloid Leukemia

Editorial Team -
Merck | MSD Exhibition booth at the 2019 annual meeting of the American Society of Medical Oncology (ASCO).

FDA Approves Pembrolizumab in Adult Patients With Relapsed or Refractory Classical...

Editorial Team -

Disitamab Vedotin Receives FDA Breakthrough Therapy Designation for Treatment of Urothelial...

Peter Hofland, Ph.D -

Japan Approves Cetuximab Saratolacan in Unresectable Locally Advanced/Recurrent Head & Neck...

Peter Hofland, Ph.D -

U.S. Food and Drug Administration Approves Pralsetinib and Companion Diagnostic

Editorial Team -

GSK Receives Conditional Marketing Authorization for Belantamab Mafodotin in Multiple Myeloma

Editorial Team -

GSK’s Belantamab Mafodotin Approved as Monotherapy for Adult Patients with R/R...

Peter Hofland, Ph.D -

FDA Approves Tafasitamab + Lenalidomide for the Treatment of Adult Patients...

Peter Hofland, Ph.D -
Doctor talking a with patient in hospital exam room. Photo courtesy: 2019 Fotolia

Inovio Receives Orphan Drug Designation for INO-3107 for Recurrent Respiratory Papillomatosis

Peter Hofland, Ph.D -

Accelerated Approval for Kite’s Brexucabtagene Autoleucel in R/R Mantle Cell Lymphoma

Peter Hofland, Ph.D -
1...345...12Page 4 of 12

LATEST NEWS

Advertisment #12
© 2001 - 2023 Sunvalley Communication, LLC. All Rights Reserved.

X